Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Pharma channel feed
Q&A: Sandoz CEO Richard Saynor on generic GLP-1s, Trump's industry impact, and Mark Cuban's company
Last month
People
Manufacturing
Enhertu combo has the makings of a new standard in HER2-positive breast cancer
Last month
R&D
Bristol Myers bets $1.5B on BioNTech's PD-L1xVEGF from Biotheus
Last month
Deals
China
Vera posts positive Phase 3 rare kidney disease data, but crowded market looms
Last month
R&D
FDA approves Moderna’s next-gen Covid vaccine, with limits on most healthy people
Last month
FDA+
Enhertu extends life by three months for some stomach cancer patients, study finds
Last month
R&D
Gilead, Merck reveal 'practice-changing' data for Trodelvy-Keytruda combo in aggressive breast cancer
Last month
R&D
Trump administration loses bid to move ahead with HHS firings, reorganization
Last month
Law
AstraZeneca agrees to pay $51M to settle ‘pay-for-delay’ class action suit
Last month
Law
HHS says it's pulled Covid shot guidance for healthy kids. The CDC vaccine schedule shows otherwise
Last month
FDA+
As a challenging first half nears a close, biopharma uncertainty persists
Last month
Financing
Deals
Pfizer's Braftovi combo doubles survival time for some colorectal cancer patients
Last month
R&D
Supreme Court to keep mulling state PBM dispute as US urges justices to decline case
Last month
Law
Eisai, Merck stave off generic competition to blockbuster cancer drug Lenvima
Last month
Law
Large pharma companies spell out reasons why tariffs will harm US investments
Last month
Manufacturing
Merck, Daiichi Sankyo scrap FDA application for HER3 ADC after survival miss
Last month
R&D
Updated: Trump administration halts more than $750M in funds for Moderna’s bird flu vaccine
Last month
Coronavirus
Novo Nordisk ‘strongly’ urges against pharma tariffs as comments flood in
Last month
Manufacturing
A new dawn for psychedelics? Compass could be the first to find out
Last month
In Focus
Axsome and Hetero settle patent fight over sleep disorder drug
Last month
Law
FDA rejects Savara’s rare lung disease drug over limited manufacturing data
Last month
FDA+
Manufacturing
Lilly to buy non-opioid pain biotech SiteOne for up to $1B
Last month
Deals
Liquidia wins approval for inhaled hypertension drug in two settings, furthering rivalry with United Therapeutics
Last month
FDA+
Biogen taps City Therapeutics in RNAi deal worth up to $1B
Last month
Startups
Deals
First page
Previous page
2
3
4
5
6
7
8
Next page
Last page